He's closed out some big winners - like a 419% gain on Celldex Therapeutics (Nasdaq: CLDX), a 226% gain on Myovant Sciences in just two months and a more than 2,000% gain on AbbVie (NYSE: ABBV) options. Would you like to score big gains like that? In this week's State of the Market, Marc outlines what he looks for to help pick big biotech winners. |
Post a Comment
Post a Comment